Login to Your Account



Mabvax going public through Telik merger

By Michael Fitzhugh
Staff Writer

Tuesday, May 13, 2014
Mabvax Therapeutics Inc., a privately held cancer immunotherapy company, is taking the fast lane to Nasdaq through a merger with publicly traded Telik Inc., which will fade out in the deal's wake.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription